Capabilities

We provide testing services to certify product and materials compliance, support quality control, and ensure the health and safety of workers and their environment. We provide assistance for clients who are not sure what tests they need. Our accredited materials characterization laboratory is the foundation of all the services of RJ Lee Group provides, including standardized testing for compliance, industrial hygiene and environmental analyses, quality control, and materials research and development.

We provide credentialed expertise supported built by robust scientific data. We provide significant support to industrial clients for product development, industrial hygiene and overall production support.

RJ Lee Group maintains a visible and respected reputation within the legal community, having offered scientific support in civil litigation matters for nearly 30 years. 

  • Product Liability 
  • Toxic Tort
  • Construction Defect
  • Fugitive Emission
  • Personal Injury
  • Patent Infringement
  • Contract Disputes
  • Insurance Subrogation

Subject Matter Experts

From our core business of providing scientific solutions to our clients, we have developed innovative products. Some are produced internally, and some have arisen from partnerships with other research organizations. 

For example, we build lab software solutions to help manage and streamline your labs data, and environmental testing products for a variety of applications. 

  • IntelliSEM is a powerful automated particle analysis system.
  • ParticleID is  a customizable cloud hosted web application used to identify foreign particulate matter and  assist with root cause investigations. 

Other products we create count particles and help keep the air and environment safe.

RJ Lee Group is a materials analysis laboratory and consulting company which serves many different industries. We offer scientific solutions such as industrial forensics services, laboratory and testing services, litigation support, and laboratory software to many industries:

Presence of Mercury Indicates Potentially Counterfeit Version of Medication

RJ Lee Group News

June 21, 2016

A client recently approached RJ Lee Group with a suspected counterfeit version of their patented injectable medication. Unlike the cloudy solution the company produces, the two samples provided were more translucent, almost clear. The client was concerned that the samples were either a counterfeit or contaminated version of their product, and asked our laboratory to provide an elemental composition of the liquid. This case study discusses the first phase of testing.

Our Biotechnology and Pharmaceutical Services scientists conducted blind testing for harmful contaminants and other substances inconsistent with medical usage. First, drops from the vials were placed on glass slides and allowed to dry. The dried droplets were then put into a Scanning Electron Microscope (SEM), where scientists saw abnormalities in the samples’ surface particulate that were determined to be mercury-rich regions. They also noticed elemental composition variance amongst certain elements present in the drug. The peak response, which indicates the relative percent composition of the elements found within the drug, was higher and lower than expected for certain elements. This suggested the possibility that the drugs were diluted, or that additional ingredients had been added to mask abnormal contaminants.

Next, Inductively Coupled Plasma (ICP) testing was conducted for the detection of seven abnormal substances, which all came back below our detection levels. As a result of the SEM/EDS findings, scientists believed mercury could be one of the contaminants in the samples. However, mercury is unstable and volatile when tested using ICP, which can affect the precision and accuracy of the results as well as the instrument’s sensitivity. Consequently, the scientists decided to perform a third type of test for mercury, using Cold Vapor Atomic Absorption. Mercury was detected in the samples.

Further elemental analysis will be conducted on the client’s approved lots of medication, which will be compared to the suspect material for inconsistencies. Phase II of this testing will be discussed in a future Case Study.

Related Posts

PTR-MS and Indoor Air Research

PTR-MS and Indoor Air Research

Indoor air quality research continues to grow substantially over the last several years. Most research prior to the 2010’s was focused on outdoor...